ioversol has been researched along with Tonsillar Neoplasms in 1 studies
Tonsillar Neoplasms: Tumors or cancer of the PALATINE TONSIL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with tonsillar cancer, the mean difference in SUV(max) between tonsils was 10." | 1.36 | Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. ( Davison, JM; Grillone, GA; Imsande, HM; Ozonoff, A; Subramaniam, RM, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davison, JM | 1 |
| Ozonoff, A | 1 |
| Imsande, HM | 1 |
| Grillone, GA | 1 |
| Subramaniam, RM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combining Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography and Plasma EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced Nasopharyngeal Carcinoma[NCT03601390] | 387 participants (Actual) | Observational | 2018-10-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for ioversol and Tonsillar Neoplasms
| Article | Year |
|---|---|
Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Carcinoma, Squamous Cell; Contrast Med | 2010 |